COVID-19 Era: Diagnosis of a Suspicious Lesion in a Telemedicine Consultation

Authors

DOI:

https://doi.org/10.30953/thmt.v7.372

Keywords:

conjunctiva, COVID-19, dysplasia, histopathology, telemedicine

Abstract

This narative challenges readers to discuss a diagnosis of a suspicious lesion during a telemedicine consultation in the era of COVID-19.

Downloads

Download data is not yet available.

References

Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - An update on the status. Mil Med Res 2020;7(1):11. https://doi.org/10.1186/s40779-020-00240-0

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. https://doi.org/10.1016/j.jaut.2020.102433

Sommer AC, Blumenthal EZ. Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2341–2352. https://doi.org/10.1007/s00417-020-04879-2

Published

2022-11-23

How to Cite

Zloto, O., & Dunlop, N. (2022). COVID-19 Era: Diagnosis of a Suspicious Lesion in a Telemedicine Consultation. Telehealth and Medicine Today, 7(5). https://doi.org/10.30953/thmt.v7.372